As biologics pipelines become increasingly diverse and demand patterns more difficult to predict, manufacturing flexibility has become a critical success factor. Continuous manufacturing and process intensification offer new opportunities to increase operational agility, optimise facility utilisation and respond more effectively to changing commercial requirements, while reducing facility footprint and resource consumption to potentially lower environmental impact without compromising product quality or supply reliability.

Drawing on FUJIFILM Biotechnologies’ MaruX™ approach, the discussion will examine how:

- Continuous bioprocessing can help move beyond traditional batch constraints

- Intensified CHO manufacturing platforms can provide the flexibility to support both current and future production needs

- Smart use of manufacturing capacity benefits both mAbs and more complex, labile molecules.

Through practical examples, learn about opportunities, challenges, and real-world considerations for implementing continuous manufacturing strategies for flexibility across the product lifecycle.

Register now to learn how MaruX™ provides flexibility of scale – helping innovators adapt with confidence as products, markets and demand evolve.